Aposense is a clinical stage molecular imaging and drug development company, focused on the introduction of novel agents based on the identification and targeting of cells undergoing apoptosis (programmed cell death).
A drug development company that has developed an innovative, nanotechnology-based system called NEOWATER. NEOWATER is a commercially available broad enabling platform upon which research, diagnostics, biotech and pharma companies can obtain disruptive price-performance results and overcome current technology barriers with an elegant implementation.
Nanolymf Ltd. is a subsidiary of Shizim Ltd. with the mission to meet the challenges of enhancing the bioavailability of highly lipophilic drugs, by introducing the market with a novel controlled release double layered nanoencapsulation delivery system.
Nicast Ltd. develops superior medical devices from electrospun nanofabric for a wide range of clinical applications. Electrospun nanofabric is a biomaterial made of ultra-thin polymer fibers, with properties that mimic those of human tissues and organs.
NST is a clinical stage molecular imaging and drug development company, focused on the introduction of novel agents (ApoSense - a small molecule 'Interfacial Nanoswitch') based on the identification and targeting of cells undergoing apoptosis.
The company's technology involves the encapsulation, at room temperature, of active ingredients in micro- and nano-sized glass (silica) matrices as well as nanospheres utilizing a chemical process called sol-gel.
A drug delivery company developing enhanced and improved therapeutic medicines in several fields. Solubest is using advanced polymer formulations to prepare nanotransporters for drugs having delivery or compliance insufficiencies.